Trump's tariff plan is unpopular! More than half of the USA population opposes imposing taxes on commodities from Mexico.

①The plan of the USA's incoming president Trump to impose tariffs does not seem to be popular among the public. According to a poll, 51% of USA voters oppose imposing tariffs on commodities from Mexico, Canada, and China; ②Standard & Poor's states that USA tariffs will increase inflation rates and reduce economic output, while some citizens and businesses are stockpiling goods due to tariff concerns, leading to a significant increase in throughput at the ports of Los Angeles and Long Beach in November.

cls.cn21:36 ET

Goldman Sachs: Assigns HANSOH PHARMA a "Buy" rating with a Target Price of 20.97 HKD.

Goldman Sachs released a research report stating that HANSOH PHARMA (03692) announced on December 18 an exclusive Global licensing agreement with Merck for the oral GLP-1 small molecule drug HS-10535, with an initial payment of $0.112 billion and milestone payments of $1.9 billion, along with royalties based on product sales. Goldman Sachs believes that HANSOH PHARMA can promote or commercially develop this product jointly in the mainland and Hong Kong-Macau or separately. Goldman Sachs rated HANSOH PHARMA as "Buy" with a Target Price of HKD 20.97. The firm noted that this is HANSOH PHARMA's second collaboration with a multinational company in the past two years, following the previous cooperation with.

新浪港股20:58 ET

Merck (MRK) Stock Moves -1.72%: What You Should Know

Zacks 17:00 ET

Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today

Kevin Travers16:16 ET

Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year

Moomoo 24/715:35 ET

Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases

Analyst Upgrades14:29 ET